EYE National Vision Holdings, Inc.
Data as of close
National Vision Holdings, Inc. (EYE) is a healthcare company in the Ophthalmic Goods industry, with a market capitalization of $1.4 billion. Shares last traded at $17.88, 40.4% below their 52-week high. Over the past year the stock is down 30.2%. EYE trades at a price-to-earnings ratio of 28.11, below the Ophthalmic Goods median of 231.29. Net profit margin is 2.5%, above the peer median of 0.5%. Revenue grew 9.0% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-07-04. Source: SEC EDGAR/XBRL.
EYE Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2017-12-30 | $171M | $2.76 | 396% |
| 2016-01-02 | $146M | $2.60 | 4027% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts).
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.15 | 2026-08-13 |
| Q1 2026 | $0.38 | 2026-05-14 |
| Q4 2025 (derived) | $0.04 | 2026-03-04 |
| FY 2025 | $0.37 | 2026-03-04 |
| Q3 2025 | $0.04 | 2025-11-06 |
| Q2 2025 | $0.11 | 2025-08-07 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Ophthalmic Goods peers
EYE vs 8 industry peers (Ophthalmic Goods), by market cap. Data as of close
| ALC | Alcon Inc | $37.3B | — | — | — | -1.02% |
| COO | Cooper Companies (The) | $12.1B | 21.17 | 2.85 | 13.5% | -1.44% |
| BLCO | Bausch & Lomb Corp | $7.1B | — | 1.32 | -2.0% | -3.30% |
| WRBY | Warby Parker Inc. | $3.2B | 434.46 | 3.47 | 0.8% | +22.76% |
| EYE | National Vision Holdings, Inc. | $1.4B | 28.11 | 0.70 | 2.5% | -0.28% |
| STAA | Staar Surgical Co | $1.3B | 2529.98 | 4.08 | 0.2% | -1.51% |
| RXST | Rxsight, Inc. | $190M | — | 1.64 | -46.3% | -9.24% |
| LUCY | Innovative Eyewear Inc | $7M | — | — | — | +0.79% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.